What oral antibiotic regimen is recommended for an uncomplicated surgical site infection in an adult without drug allergies or renal/hepatic impairment, and what alternatives should be used for penicillin allergy, MRSA risk, or the need for gram‑negative coverage?

Oral Antibiotic Treatment for Surgical Site Infections

For uncomplicated surgical site infections after trunk or extremity surgery (away from axilla/perineum), use cephalexin or dicloxacillin as first-line oral therapy; for perineum/axilla infections or GI/GU tract surgery, use ceftriaxone or levofloxacin plus metronidazole; and for confirmed or high-risk MRSA, use trimethoprim-sulfamethoxazole, doxycycline, or clindamycin. 1, 2

Algorithm for Oral Antibiotic Selection

Step 1: Determine Surgical Site Location and Contamination Risk

Clean trunk/extremity surgery (away from axilla/perineum):

• First-line: Cephalexin, dicloxacillin, or cloxacillin 1, 2
• These target methicillin-susceptible S. aureus (MSSA), the predominant pathogen in clean surgical sites
• Duration: 7 days for most uncomplicated infections 1

Axilla or perineum surgery:

• First-line: Ceftriaxone or levofloxacin PLUS metronidazole 1, 2
• Requires broader coverage including anaerobes due to proximity to skin flora and potential polymicrobial infection

GI or genitourinary tract surgery:

• First-line: Levofloxacin plus metronidazole, OR amoxicillin-clavulanate 1, 2
• Must cover gram-negatives and anaerobes
• Alternative: Ceftriaxone plus metronidazole 2

Step 2: Assess for MRSA Risk

If MRSA suspected or confirmed:

• First-line oral agents: Trimethoprim-sulfamethoxazole (TMP-SMX), doxycycline, or clindamycin 1, 3
• TMP-SMX and doxycycline are preferred for non-multiresistant community-acquired MRSA 3
• Clindamycin is effective but resistance patterns vary regionally 1

Important caveat: Most community-acquired MRSA strains in many regions are non-multiresistant and respond well to these oral agents, whereas hospital-acquired multiresistant MRSA typically requires combination therapy (rifampicin plus fusidic acid) 3

Step 3: Manage Penicillin Allergy

Critical pitfall: Reported penicillin allergy leads to suboptimal antibiotic use and increased SSI rates 4, 5, 6

For patients reporting penicillin allergy:

• Low-risk allergy history (distant, mild reaction): Cephalosporins (especially cephalexin or cefazolin) can be safely used—cross-reactivity risk is <1-3% 5, 6
• Type 1 hypersensitivity (anaphylaxis, urticaria, angioedema): Avoid all β-lactams; use fluoroquinolones (levofloxacin) with metronidazole for mixed infections, or clindamycin/TMP-SMX for gram-positive coverage 1, 5
• Best practice: Formal allergy evaluation should be considered preoperatively to enable β-lactam use, as alternatives like clindamycin are associated with higher SSI rates (5.6% vs 1.4% for β-lactams) 4

Evidence Quality and Nuances

The IDSA 2014 guidelines 1 provide the foundational framework, emphasizing that most surgical site infections involve S. aureus and require targeted therapy based on methicillin susceptibility. The WHO 2024 guidelines 2 reinforce these recommendations with updated antimicrobial stewardship principles, categorizing amoxicillin-clavulanate, cloxacillin, and cephalexin as "Access" antibiotics for mild infections.

Key divergence: While older evidence 3 from 2005 emphasizes penicillinase-resistant penicillins (flucloxacillin, dicloxacillin) as gold standard for MSSA, contemporary practice increasingly favors first-generation cephalosporins (cephalexin) due to better tolerability and equivalent efficacy 1, 2.

Emerging resistance concern: Recent data 7 from Ghana shows high resistance to cephalosporins and penicillins in wound isolates, but this reflects prophylaxis patterns rather than treatment failure in established infections. Aminoglycosides and carbapenems remain highly effective, but these are parenteral agents reserved for severe infections 7.

Common Pitfalls to Avoid

1. Overusing clindamycin in penicillin-allergic patients: This increases SSI risk compared to β-lactams 4. Risk-stratify the allergy and use cephalosporins when safe.

2. Inadequate anaerobic coverage: Infections near the perineum, axilla, or following GI/GU surgery require metronidazole or amoxicillin-clavulanate 1, 2.

3. Treating fever in first 48 hours post-op as SSI: Early fever is often non-infectious; avoid antibiotics unless systemic illness, wound drainage, or marked inflammation present 1.

4. Monotherapy for multiresistant MRSA: Hospital-acquired multiresistant strains require combination therapy (rifampicin plus fusidic acid) to prevent resistance 3.

5. Excessive duration: Seven days is sufficient for uncomplicated SSI 1. Prolonged courses increase resistance and adverse effects without improving outcomes.